Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors
Trial ID or NCT#
Status
Purpose
This clinical trial studies how well yttrium-90 (Y90) glass microspheres positron emission tomography (PET)/computed tomography (CT) works in imaging patients with liver tumors . Images produced by PET/CT may provide better information about the distribution of particles, such as Y90 glass microspheres, delivered for selective internal radiation therapy (SIRT) as compared to regular medical care images useing technetium Tc-99m albumin-aggregated single photon emission computed tomography (SPECT)/CT images.
Official Title
High Quality Imaging and Dosimetry of Yttrium-90 (90Y) SIRT Using a Digital PET/CT
Eligibility Criteria
- - Patient provides written informed consent - Patient is referred for 90Y SIRT radioembolization of liver tumor(s) - Patient is capable of complying with study procedures - Patient is able to remain still for duration of imaging procedure (approximately 30 minutes total for digital PET/CT)
- - Patient is pregnant or nursing
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Risa Jiron
650-736-1598
View on ClinicalTrials.gov